Azitra stock is among today’s top performers. Why is AZTR stock up today?Azitra To Raise $10.5 Million For Peptide ResearchAzitra's spike is being fueled by a securities purchase agreement with healthcare-focused institutional investors for gross proceeds of up to $31.4 million, with Series B and C warrants exercisable at $0.123 per share and Series A convertible preferred priced at $1,000 per share. The sum includes initial gross proceeds of approximately $10.5 million and up to an additional $20.9 million ...